Neurogene (Neurogene) Accounts Payable & Accrued Expense : $6.25 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Neurogene Accounts Payable & Accrued Expense?

Neurogene's quarterly accounts payable & accrued expense increased from Sep. 2023 ($4.75 Mil) to Dec. 2023 ($13.38 Mil) but then declined from Dec. 2023 ($13.38 Mil) to Mar. 2024 ($6.25 Mil).

Neurogene's annual accounts payable & accrued expense declined from Dec. 2021 ($6.96 Mil) to Dec. 2022 ($2.43 Mil) but then increased from Dec. 2022 ($2.43 Mil) to Dec. 2023 ($13.38 Mil).

Neurogene Accounts Payable & Accrued Expense Historical Data

The historical data trend for Neurogene's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurogene Accounts Payable & Accrued Expense Chart

Neurogene Annual Data

Trend

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

6.96

2.43

13.38

Neurogene Quarterly Data
	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			-	3.63	4.75	13.38	6.25

Neurogene Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Neurogene (Neurogene) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurogene Inc (NAS:NGNE) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

535 W 24th Street, 5th Floor, New York, NY, USA, 10011

Website

https://www.neurogene.com

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Neurogene (Neurogene) Headlines

From GuruFocus

Neurogene Announces Business Update and 2024 Outlook

By Business Wire • 01-05-2024

Neurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million

By Business Wire • 12-19-2023